These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32603315)

  • 21. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.
    Learn CA; Grossi PM; Schmittling RJ; Xie W; Mitchell DA; Karikari I; Wei Z; Dressman H; Sampson JH
    J Neuroimmunol; 2007 Jan; 182(1-2):63-72. PubMed ID: 17137636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
    Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
    J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Purity as an Underlying Key Factor in Glioma.
    Zhang C; Cheng W; Ren X; Wang Z; Liu X; Li G; Han S; Jiang T; Wu A
    Clin Cancer Res; 2017 Oct; 23(20):6279-6291. PubMed ID: 28754819
    [No Abstract]   [Full Text] [Related]  

  • 25. Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas.
    Chen Z; Liu C; Zhang C; Xia Y; Peng J; Miao C; Luo Q
    Front Immunol; 2024; 15():1475206. PubMed ID: 39380997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of immune evasion by gliomas.
    Rolle CE; Sengupta S; Lesniak MS
    Adv Exp Med Biol; 2012; 746():53-76. PubMed ID: 22639159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
    DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
    Front Immunol; 2020; 11():1402. PubMed ID: 32765498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of microglia and P2X7 receptors in gliomas.
    Kan LK; Williams D; Drummond K; O'Brien T; Monif M
    J Neuroimmunol; 2019 Jul; 332():138-146. PubMed ID: 31031209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells.
    Wang J; Liu P; Xin S; Wang Z; Li J
    Exp Cell Res; 2017 Nov; 360(2):66-73. PubMed ID: 28782555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8
    Kane JR; Zhao J; Tsujiuchi T; Laffleur B; Arrieta VA; Mahajan A; Rao G; Mela A; Dmello C; Chen L; Zhang DY; González-Buendia E; Lee-Chang C; Xiao T; Rothschild G; Basu U; Horbinski C; Lesniak MS; Heimberger AB; Rabadan R; Canoll P; Sonabend AM
    Clin Cancer Res; 2020 Aug; 26(16):4390-4401. PubMed ID: 32430477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDIA3 correlates with clinical malignant features and immune signature in human gliomas.
    Zhang H; Zhou Y; Cheng Q; Dai Z; Wang Z; Liu F; Fan F; Cui B; Cao H
    Aging (Albany NY); 2020 Aug; 12(15):15392-15413. PubMed ID: 32687065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
    Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
    Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor localization of an anti-TGF-β antibody and its effects on gliomas.
    Hülper P; Schulz-Schaeffer W; Dullin C; Hoffmann P; Harper J; Kurtzberg L; Lonning S; Kugler W; Lakomek M; Erdlenbruch B
    Int J Oncol; 2011 Jan; 38(1):51-9. PubMed ID: 21109925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.
    Najem H; Khasraw M; Heimberger AB
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
    Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
    Front Immunol; 2019; 10():1756. PubMed ID: 31428092
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.
    Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B
    J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.